Orthofix Medical Inc. logo

Orthofix Medical Inc.

OFIX | NASDAQ
Chart Builder DCF Calculator
$8.95
+$0.24 (+2.76%)
At close: Sep 21, 2026, 4:00 PM ET
$9.02
+$0.07 (+0.82%)
Pre-market: Sep 22, 2026, 4:42 AM ET

Market Data

Market Cap
$352.07M
Enterprise Value
$492.58M
Beta
0.65
Average Volume
402.66K
Shares Outstanding (Diluted)
40.91M
Shares Change YoY
3.56%
Institutional Ownership
89.08%
Exchange
NASDAQ
ISIN
US68752M1080

Price Performance

Price Change 1M
-12.3%
Price Change 3M
-1.6%
Price Change 6M
-25.0%
Price Change YTD
-39.7%
Price Change 1Y
-39.8%
Price Change 3Y
-28.4%
Price Change 5Y
-77.0%
1M CAGR (ann.)
-17.8%
1Y CAGR (ann.)
-41.7%
5Y CAGR (ann.)
-26.5%
All-Time CAGR
-7.7%

Valuation

PE Ratio
-5.81
Forward PE
N/A
PEG Ratio
-0.08
Forward PEG
0.29
PS Ratio
0.43
Forward PS
0.40
PB Ratio
0.84
P/FCF Ratio
-6.54
P/Adj. FCF Ratio
-3.48
P/OCF Ratio
21.31
EV/Sales
0.59
EV/EBIT
-12.98
EV/EBITDA
4.60
EV/FCF
-8.91
Earnings Yield
-17.2%
FCF Yield
-15.3%
Adj. FCF Yield
-28.8%

Financial Health

Net Debt
$117.78M
Total Debt
$234.62M
Cash & Short-Term Investments
$103.81M
Total Assets
$873.02M
Current Ratio
2.84
Quick Ratio
1.67
Debt / Equity Ratio
0.55
Debt / EBITDA
2.19
Debt / FCF
-4.24
OCF / Debt
-0.00
Interest Coverage
-1.22
Altman Z-Score
1.03
Piotroski F-Score
5

Margins & Profitability

Gross Profit Margin
69.6%
Operating Profit Margin
-3.0%
EBITDA Margin
12.9%
Net Profit Margin
-7.4%
FCF Margin
-6.6%
Adj. FCF Margin
-12.5%
SBC / Revenue
5.1%
SBC Impact (per share)
-88.1%

Returns

Return on Assets
-7.1%
Return on Equity
-14.1%
Return on Invested Capital
-3.5%
Return on Capital Employed
-3.5%
Return on Tangible Assets
-10.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
11.7%
Revenue CAGR 5Y
12.8%
Revenue CAGR 10Y
7.4%
EPS CAGR 3Y
31.5%
EPS CAGR 5Y
4.2%
EPS CAGR 10Y
-31.6%
FCF CAGR 3Y
22.8%
FCF CAGR 5Y
-0.8%
FCF CAGR 10Y
-147.0%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
17
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
6.4%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
$0.11
EPS Growth Est (next Q)
-119.3%
Revenue Est (next Q)
$210.69M
Revenue Growth Est (next Q)
2.5%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$13.40
Price Target Upside
49.7%

Cash Flow

Operating Cash Flow
$-560.71K
Free Cash Flow
$-55.3M
Adj. Free Cash Flow
$-104.05M
FCF Per Share
-$0.66
OCF Per Share
$0.42
OCF/S Ratio
2.0%

Income Statement

Revenue
$833.19M
Gross Profit
$579.81M
Operating Income
$-25.42M
EBITDA
$107.11M
Net Income
$-61.72M
EPS (Diluted)
-$1.54
Revenue / Employee
$519.12K
Profit / Employee
$-38.46K
Employees
1,605

© 2026 bestshares.com. All rights reserved.